Stock Movers cover image

Nike, Trump Media End Day Higher; Corcept Plunges

Stock Movers

00:00

Corcept's drug rejection crushes shares

The hosts discuss the FDA rejection of Corcept's relacorilant and the resulting steep market value decline.

Play episode from 05:21
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app